Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 7, Pages 3262-3267
Publisher
American Society for Microbiology
Online
2013-04-30
DOI
10.1128/aac.00251-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies
- (2013) Yeon-Joo Lee et al. MEDICAL MYCOLOGY
- Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
- (2012) Natalie K. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections
- (2012) Andres Pascual et al. CLINICAL INFECTIOUS DISEASES
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of the effect of obesity on voriconazole serum concentrations
- (2012) E. Koselke et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies
- (2012) M. Hoenigl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients
- (2012) Martin Hoenigl et al. JOURNAL OF INFECTION
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
- (2012) Alicia Gómez-López et al. MEDICAL MYCOLOGY
- Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies
- (2012) Martin Hoenigl et al. MEDICAL MYCOLOGY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Population Pharmacokinetics of Voriconazole in Adults
- (2011) William W. Hope ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients
- (2011) Si-Hyun Kim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
- (2011) Arwa Hassan et al. THERAPEUTIC DRUG MONITORING
- Therapeutic Drug Monitoring of Voriconazole in Children
- (2011) Jennifer Chen et al. THERAPEUTIC DRUG MONITORING
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
- (2010) Dimitrios P. Kontoyiannis et al. CLINICAL INFECTIOUS DISEASES
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
- (2010) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) S. M. Trifilio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now